Search
  • Investor Portal
  • Contact
Amadeus Capital
  • Home
  • Who we are
    • The Team
  • How we invest
    • Submit a proposal
  • Companies
    • AI and Machine Learning
    • Consumer Services
    • Cyber Security
    • Digital Health and Medical Technology
    • Digital Media
    • Enterprise Software
    • FinTech, InsurTech and RegTech
    • Semiconductors and Displays
    • Telecoms Infrastructure
  • Careers
    • Portfolio Companies
    • Amadeus
  • News
    • Press Releases
    • Blogs
    • Podcasts
    • Video Library
    • Downloads
  • Investor relations
    • Amadeus Investor Portal
    • Amadeus Early Stage EIS Fund and Portal
  • Investor Portal
  • Contact

Home > News > amadeus backing quibim

News

Quibim QP Prostate platform on a laptop and computer screen, showing AI-powered imaging biomarkers.

Latest Press Release: 28th January 2025

Quibim Announces $50 Million in Series A Financing

Funding drives the expansion of Quibim’s product pipeline and foundational AI models and accelerates global commercial growth. Asabys and Buenavista lead the round, joined by UI Investissements, GoHub Ventures and insiders; Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind and individual investors. Valencia (Spain), and New York (USA), January 28, 2025 – [...]

Read in full

  • Blog: 22nd July 2020

    Early Bird Gets The Worm – our investment in Quibim

    The integration of medical imaging, artificial intelligence and radiomics is set to play a pivotal role in precision and personalised healthcare – and we are delighted to be backing a pioneer, Quibim , and its founders, Dr. Ángel Alberich-Bayarri and Prof. Luis Marti-Bonmati . Here is the story. Every year nine million people die from cancer alone, all too often because they [...]

    • How we invest

    • Have you seen...

      Meet the team

    • Resources

    • Terms & Conditions
    • Privacy Policy
    • Cookie Policy
    • Site Credits

    © Copyright 2025 Amadeus Capital Partners Ltd

    Authorised and regulated by the Financial Conduct Authority